Involvement of CCR3-reactive chemokines in eosinophil survival

International Archives of Allergy and Immunology

Volumn 130, Issue 2, 2003, Pages 150-157

  Shinagawa, Kazuhiko ^a   Trifilieff, Alexandre ^b   Anderson, Gary P ^c  

^a KISSEI PHARMACEUTICAL CO LTD   (Japan)

^b NOVARTIS HORSHAM RESEARCH CENTRE   (United Kingdom)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Apoptosis; CC chemokine; Eotaxin; GM CSF

Indexed keywords

ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR3; EOTAXIN; EOTAXIN 2; EOTAXIN 3; PROPIDIUM IODIDE; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EOSINOPHIL; EXPOSURE; LUNG LAVAGE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PURIFICATION; STAINING;

ANIMALS; APOPTOSIS; BRONCHOALVEOLAR LAVAGE FLUID; CELL SURVIVAL; CHEMOKINES, CC; CYTOKINES; EOSINOPHILS; FLOW CYTOMETRY; MACROPHAGE INFLAMMATORY PROTEIN-1; MALE; MICE; MICE, INBRED BALB C; MONOCYTE CHEMOATTRACTANT PROTEINS; RANTES; RECEPTORS, CHEMOKINE; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 0037225286     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069005     Document Type: Article

References (31)

1. Weller PF: The immunobiology of eosinophils. N Engl J Med 1991;324:1110-1118.
2. Seminario MC, Gleich GJ: The role of eosinophils in the pathogenesis of asthma. Curr Opin Immunol 1994;6:860-864.
3. Sedgwick JB, Calhoun WJ, Gleich GJ, Kita H, Abrams JS, Schwartz LB, Volovitz B, Ben-Yaakov M, Busse WW: Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. Am Rev Respir Dis 1991;144:1274-1281.
4. Collins DS, Dupuis R, Gleich GJ, Bartemes KR, Koh YY, Pollice M, Albertine KH, Fish JE, Peters SP: Immunoglobulin E-mediated increase in vascular permeability correlates with eosinophilic inflammation. Am Rev Respir Dis 1993;147:677-683.
5. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P, Michel FB: Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-1039.
6. Gonzalo JA, Lloyd CM, Wen D, Albar JP, Wells TN, Proudfoot A, Martinez AC, Dorf M, Bjerke T, Coyle AJ, Gutierrez-Ramos JC: The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med 1998;188:157-167.
7. Resnick MB, Weller PF: Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol 1993;8:349-355.
8. Ganzalo JA, Jia GQ, Aguirre V, Friend D, Coyle AJ, Jenkins NA, Lin GS, Katz H, Lichtman A, Copeland N, Kopf M, Gutierrez-Ramos JC: Mouse eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but is not restricted to a Th2-type response. Immunity 1996;4:1-14.
9. Heath H, Qin S, Rao P, Wu L, LaRosa G, Kassam N, Ponath PD, Mackay CR: Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J Clin Invest 1997;99:178-184.
10. Lloyd CM, Delaney T, Nguyen T, Tian J, Martinez-AC, Coyle AJ, Gutierrez-Ramos JC: CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. J Exp Med 2000;191:265-274.
11. Ying S, Robinson DS, Meng Q, Rottman J, Kennedy R, Ringler DJ, Mackay CR, Daugherty BL, Springer MS, Durham SR, Williams TJ, Kay AB: Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol 1997;27:3507-3516.
12. Humbles AA, Conroy DM, Marleau S, Rankin SM, Palframan RT, Proudfoot AE, Wells TN, Li D, Jeffery PK, Griffiths-Johnson DA, Williams TJ, Jose PJ: Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: Analysis in aguinea pig model in vivo. J Exp Med 1997;186:601-612.
13. Griffiths-Johnson DA, Collins PD, Rossi AG,Jose PJ, Williams TJ: The chemokine, eotaxin activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem Biophys Res Commun 1993;197:1167-1172.
14. Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty NF, Truong O, Hsuan JJ, Williams TJ: Eotaxin: A potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994;179:881-887.
15. Rothenberg ME, Luster AD, Lilly CM, Drazen JM, Leder P: Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung. J Exp Med 1995;181:1211-1216.
16. Nakamura H, Weiss ST, Israel E, Luster AD, Drazen JM, Lilly CM: Eotaxin and impaired lung function in asthma. Am J Respir Crit Care Med 1999;160:1952-1956.
17. Owen WF, Rothenberg ME, Silberstein DS, Gasson JC, Stevens RL, Austen KF, Soberman RJ: Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts. J Exp Med 1987;166:129-141
18. Rothenberg ME, Petersen J, Stevens RL, Silberstein DS, McKenzie DT, Austen KF, Owen WF: IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity. J Immunol 1989;143:2311-2316.
19. Rothenberg ME, Owen WF, Silberstein DS, Woods J, Soberman RJ, Austen KF, Stevens RL: Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J Clin Invest 1988;81:1986-1992.
20. Tsuyuki S, Bertrand C, Erard F, Trifilieff A, Tsuyuki J, Wesp M, Anderson GP, Coyle AJ: Activation of the fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways. J Clin Invest 1995;96:2924-2931.
21. Shinagawa K, Anderson GP: Rapid isolation of homogenous murine bronchoalveolar lavage fluid eosinophils by differential lectin affinity interaction and negative selection. J Immunol Methods 2000;237:65-72.
22. Kitagaki K, Nagai H, Hayashi S, Totsuka T: Facilitation of apoptosis by cyclosporins A and H, but not FK506 in mouse bronchial eosinophils. Eur J Pharmacol 1997;337:283-289.
23. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139:271-279.
24. Nakajima T, Yamada H, Iikura M, Miyamasu M, Izumi S, Shida H, Ohta K, Imai T, Yoshie O, Mochizuki M, Schroder JM, Morita Y, Yamamoto K, Hirai K: Intracellular localization and release of eotaxin from normal eosinophils. FEBS Lett 1998;434:226-230.
25. Rankin SM, Conroy DM, Williams TJ: Eotaxin and eosinophil recruitment: Implications for human disease. Mol Med Today 2000;6:20-27.
26. Mould AW, Ramsay AJ, Matthaei KI, Young IG, Rothenberg ME, Foster PS: The effect of IL-5 and eotaxin expression in the lung on eosinophil trafficking and degranulation and the induction of bronchial hyperreactivity. J Immunol 2000;164:2142-2150.
27. Kim J, Merry AC, Nemzek JA, Bolgos GL, Siddiqui J, Remick DG: Eotaxin represents the principal eosinophil chemoattractant in a novel murine asthma model induced by house dust containing cockroach allergens. J Immunol 2001;167:2808-2815.
28. Zimmermann N, Hogan SP, Mishra A, Brandt EB, Bodette TR, Pope SM, Finkelman FD, Rothenberg ME: Murine eotaxin-2: A constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression. J Immunol 2000;165:5839-5846.
29. Wedi B, Raap U, Lewrick U, Kapp A: IL-4-induced apoptosis in peripheral blood eosinophils. J Allergy Clin Immunol 1998;102:1013-1020.
30. Iversen PO, Robinson D, Ying S, Meng Q, Kay AB, Clark-Lewis I, Lopez AF: The GM-CSF analogue E21R induces apoptosis of normal and activated eosinophils. Am J Respir Crit Care Med 1997;156:1628-1632.
31. Rothenberg ME, Ownbey R, Mehlhop PD, Loiselle PM, van de Rijn M, Bonventre JV, Oett-gen HC, Leder P, Luster AD: Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Mol Med 1996;2:334-348.